Diagnosis of dengue: An update

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 8, 2012, Pages 895-907

  Tang, Kin Fai ^a   Ooi, Eng Eong ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

dengue; diagnostics; early diagnosis; surveillance; vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN DETECTION; CLINICAL FEATURE; DENGUE; HEALTH CARE QUALITY; HUMAN; LABORATORY DIAGNOSIS; NONHUMAN; PATIENT ASSESSMENT; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS ISOLATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DENGUE; DENGUE VACCINES; DENGUE VIRUS; EARLY DIAGNOSIS; HUMANS; NEUTRALIZATION TESTS; PROGNOSIS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VACCINATION; VIREMIA;

EID: 84867061789     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.76     Document Type: Review

References (155)

1. WHO. DENGUE: Guidelines for Diagnosis, Treatment, Prevention and Control-New Edition. WHO, Geneva, Switzerland (2009).
2. Westaway EG, Blok J. Taxonomy and evolutionary relationships of flavivirus. In: Dengue and Dengue Hemorrhagic Fever. Gubler DJ, Kuno G (Eds). CAB International, London, UK (1997).
3. Chambers TJ, Weir RC, Grakoui A et al. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc. Natl Acad. Sci. USA 87(22), 8898-8902 (1990).
4. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229(4715), 726-733 (1985).
5. Harris E, Holden KL, Edgil D, Polacek C, Clyde K. Molecular biology of flaviviruses. Novartis Found. Symp. 277, 23-39; discussion 40, 71-73, 251-253 (2006).
6. Sabin AB. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1(1), 30-50 (1952).
7. WHO-SEARO. Guidelines for Treatment of Dengue Fever/Dengue Haemorrhagic Fever in Small Hospitals. WHO-SEARO, New Delhi, India (1999).
8. Halstead SB, O'Rourke EJ. Antibodyenhanced dengue virus infection in primate leukocytes. Nature 265(5596), 739-741 (1977).
9. Halstead SB, Venkateshan CN, Gentry MK, Larsen LK. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132(3), 1529-1532 (1984).
10. Halstead SB. Neutralization and antibodydependent enhancement of dengue viruses. Adv. Virus Res. 60, 421-467 (2003).
11. Sessions OM, Barrows NJ, Souza-Neto JA et al. Discovery of insect and human dengue virus host factors. Nature 458(7241), 1047-1050 (2009).
12. Low JG, Ong A, Tan LK et al. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl. Trop. Dis. 5(5), e1191 (2011).
13. Khor CC, Chau TN, Pang J et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat. Genet. 43(11), 1139-1141 (2011).
14. Pastorino B, Nougairède A, Wurtz N, Gould E, de Lamballerie X. Role of host cell factors in flavivirus infection: implications for pathogenesis and development of antiviral drugs. Antiviral Res. 87(3), 281-294 (2010).
15. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 22(4), 564-581 (2009).
16. Rico-Hasse R. Dengue virus virulence and transmission determinants. Curr. Trop. Microbiol. Immunol. 338, 45-55 (2010).
17. Tuiskunen A, Wahlström M, Bergström J, Buchy P, Leparc-Goffart I, Lundkvist A. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome. Virol. J. 8, 398 (2011).
18. OhAinle M, Balmaseda A, Macalalad AR et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci. Transl. Med. 3(114), 114ra128 (2011).
19. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11(3), 480-496 (1998).
20. Xu G, Dong H, Shi N et al. An outbreak of dengue virus serotype 1 infection in Cixi, Ningbo, People's Republic of China, 2004, associated with a traveler from Thailand and high density of Aedes albopictus. Am. J. Trop. Med. Hyg. 76(6), 1182-1188 (2007).
21. Lambrechts L, Scott TW, Gubler DJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl. Trop. Dis. 4(5), e646 (2010).
22. Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerging Infect. Dis. 12(6), 887-893 (2006).
23. Sabin AB, Schlesinger RW. Production of immunity to dengue with virus modified by propagation in mice. Science 101(2634), 640-642 (1945).
24. WHO. Dengue Vaccine Development: the Role of the WHO South-East Asia Regional Office. WHO, Geneva, Switzerland (2010).
25. Halstead SB, Diwan AR, Marchette NJ, Palumbo NE, Srisukonth L. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels. Am. J. Trop. Med. Hyg. 33(4), 654-665 (1984).
26. Halstead SB, Marchette NJ, Diwan AR, Palumbo NE, Putvatana R. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels. Am. J. Trop. Med. Hyg. 33(4), 666-671 (1984).
27. Halstead SB, Marchette NJ, Diwan AR, Palumbo NE, Putvatana R, Larsen LK. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells. Am. J. Trop. Med. Hyg. 33(4), 672-678 (1984).
28. Halstead SB, Eckels KH, Putvatana R, Larsen LK, Marchette NJ. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells. Am. J. Trop. Med. Hyg. 33(4), 679-683 (1984).
29. Halstead SB, Marchette NJ. Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii. Am. J. Trop. Med. Hyg. 69(6 Suppl.), 5-11 (2003).
30. Halstead SB. Studies on the attenuation of dengue 4. Asian J. Infect. Dis. 2, 112-117 (1978).
31. Russell PK. Progress toward dengue vaccines. Asian J. Infect. Dis. 2, 118-120 (1978).
32. Swaminathan S, Batra G, Khanna N. Dengue vaccines: state-of-the-art. Expert Opin. Ther. Pat. 20(6), 819-835 (2010).
33. Gubler DJ. Emerging vector-borne flavivirus diseases: are vaccines the solution? Expert Rev. Vaccines 10(5), 563-565 (2011).
34. Coller BA, Clements DE. Dengue vaccines: progress and challenges. Curr. Opin. Immunol. 23(3), 391-398 (2011).
35. WHO. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control (2nd Edition). WHO, Geneva, Switzerland (1997).
36. Tanner L, Schreiber M, Low JG et al. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl. Trop. Dis. 2(3), e196 (2008).
37. Potts JA, Thomas SJ, Srikiatkhachorn A et al. Classification of dengue illness based on readily available laboratory data. Am. J. Trop. Med. Hyg. 83(4), 781-788 (2010).
38. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop. Med. Int. Health 13(11), 1328-1340 (2008).
39. Vaughn DW, Green S, Kalayanarooj S et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181(1), 2-9 (2000).
40. Jarman RG, Nisalak A, Anderson KB et al. Factors influencing dengue virus isolation by C6/36 cell culture and mosquito inoculation of nested PCR-positive clinical samples. Am. J. Trop. Med. Hyg. 84(2), 218-223 (2011).
41. Kuberski TT, Rosen L. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am. J. Trop. Med. Hyg. 26(3), 533-537 (1977).
42. Kuberski TT, Rosen L. Identification of dengue viruses using complement fixing antigen produced in mosquitoes. Am. J. Trop. Med. Hyg. 26(3), 538-543 (1977).
43. Gubler DJ, Nalim S, Tan R, Saipan H, Sulianti Saroso J. Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am. J. Trop. Med. Hyg. 28(6), 1045-1052 (1979).
44. Thet W. Detection of dengue virus by immunofluorescence after intracerebral inoculation of mosquitoes. Lancet 1(8262), 53-54 (1982).
45. Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 48(1), 84-90 (2006).
46. Meiklejohn G, England B, Lennette EH. Propagation of dengue virus strains in unweaned mice. Am. J. Trop. Med. Hyg. 1(1), 51-58 (1952).
47. Sabin AB. The dengue group of viruses and its family relationships. Bacteriol. Rev. 14(3), 225-232 (1950).
48. Yuill TM, Sukhavachana P, Nisalak A, Russell PK. Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am. J. Trop. Med. Hyg. 17(3), 441-448 (1968).
49. Matsumura T, Stollar V, Schlesinger RW. Studies on the nature of dengue viruses. V. Structure and development of dengue virus in Vero cells. Virology 46(2), 344-355 (1971).
50. Fujita N, Tamura M, Hotta S. Dengue virus plaque formation on microplate cultures and its application to virus neutralization (38564). Proc. Soc. Exp. Biol. Med. 148(2), 472-475 (1975).
51. Igarashi A. Isolation of a Singh's Aedes albopictus cell clone sensitive to dengue and chikungunya viruses. J. Gen. Virol. 40(3), 531-544 (1978).
52. Tesh RB. A method for the isolation and identification of dengue viruses, using mosquito cell cultures. Am. J. Trop. Med. Hyg. 28(6), 1053-1059 (1979).
53. Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am. J. Trop. Med. Hyg. 33(1), 158-165 (1984).
54. Chua KB, Mustafa B, Abdul Wahab AH et al. A comparative evaluation of dengue diagnostic tests based on single-acute serum samples for laboratory confirmation of acute dengue. Malays. J. Pathol. 33(1), 13-20 (2011).
55. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptasepolymerase chain reaction. J. Clin. Microbiol. 30(3), 545-551 (1992).
56. Harris E, Roberts TG, Smith L et al. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J. Clin. Microbiol. 36(9), 2634-2639 (1998).
57. Raengsakulrach B, Nisalak A, Maneekarn N et al. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. J. Virol. Methods 105(2), 219-232 (2002).
58. Gijavanekar C, Añez-Lingerfelt M, Feng C et al. PCR detection of nearly any dengue virus strain using a highly sensitive primer 'cocktail'. FEBS J. 278(10), 1676-1687 (2011).
59. Yong YK, Thayan R, Chong HT, Tan CT, Sekaran SD. Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR. Singapore Med. J. 48(7), 662-668 (2007).
60. Upanan S, Cabrera-Hernandez A, Ekkapongpisit M, Smith DR. A simplified PCR methodology for semiquantitatively analyzing dengue viruses. Jpn. J. Infect. Dis. 59(6), 383-387 (2006).
61. Dash PK, Parida M, Santhosh SR et al. Development and evaluation of a 1-step duplex reverse transcription polymerase chain reaction for differential diagnosis of chikungunya and dengue infection. Diagn. Microbiol. Infect. Dis. 62(1), 52-57 (2008).
62. Barkham TM, Chung YK, Tang KF, Ooi EE. The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory. Trans. R. Soc. Trop. Med. Hyg. 100(2), 142-148 (2006).
63. Chutinimitkul S, Payungporn S, Theamboonlers A, Poovorawan Y. Dengue typing assay based on real-time PCR using SYBR Green I. J. Virol. Methods 129(1), 8-15 (2005).
64. Chien LJ, Liao TL, Shu PY, Huang JH, Gubler DJ, Chang GJ. Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J. Clin. Microbiol. 44(4), 1295-1304 (2006).
65. Lai YL, Chung YK, Tan HC et al. Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus. J. Clin. Microbiol. 45(3), 935-941 (2007).
66. Pok KY, Lai YL, Sng J, Ng LC. Evaluation of nonstructural 1 antigen assays for the diagnosis and surveillance of dengue in Singapore. Vector Borne Zoonotic Dis. 10(10), 1009-1016 (2010).
67. Hue KD, Tuan TV, Thi HT et al. Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. J. Virol. Methods 177(2), 168-173 (2011).
68. Hirayama T, Mizuno Y, Takeshita N et al. Detection of dengue virus genome in urine by real-time reverse transcriptase PCR: a laboratory diagnostic method useful after disappearance of the genome in serum. J. Clin. Microbiol. 50(6), 2047-2052 (2012).
69. Tripathi NK, Shrivastava A, Dash PK, Jana AM. Detection of dengue virus. Methods Mol. Biol. 665, 51-64 (2011).
70. Leparc-Goffart I, Baragatti M, Temmam S et al. Development and validation of real-time one-step reverse transcription-PCR for the detection and typing of dengue viruses. J. Clin. Virol. 45(1), 61-66 (2009).
71. Gurukumar KR, Priyadarshini D, Patil JA et al. Development of real-time PCR for detection and quantitation of dengue viruses. Virol. J. 6, 10 (2009).
72. Poloni TR, Oliveira AS, Alfonso HL et al. Detection of dengue virus in saliva and urine by real-time RT-PCR. Virol. J. 7, 22 (2010).
73. Sadon N, Delers A, Jarman RG et al. A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples. J. Virol. Methods 153(1), 1-6 (2008).
74. Singh K, Lale A, Eong Ooi E et al. A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of dengue fever. J. Mol. Diagn. 8(5), 613-616; quiz 617 (2006).
75. Kong YY, Thay CH, Tin TC, Devi S. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. J. Virol. Methods 138(1-2), 123-130 (2006).
76. Saxena P, Dash PK, Santhosh SR, Shrivastava A, Parida M, Rao PL. Development and evaluation of one step single tube multiplex RT-PCR for rapid detection and typing of dengue viruses. Virol. J. 5, 20 (2008).
77. Dos Santos HW, Poloni TR, Souza KP et al. A simple one-step real-time RT-PCR for diagnosis of dengue virus infection. J. Med. Virol. 80(8), 1426-1433 (2008).
78. Klungthong C, Gibbons RV, Thaisomboonsuk B et al. Dengue virus detection using whole blood for reverse transcriptase PCR and virus isolation. J. Clin. Microbiol. 45(8), 2480-2485 (2007).
79. Watthanaworawit W, Turner P, Turner CL et al. A prospective evaluation of diagnostic methodologies for the acute diagnosis of dengue virus infection on the Thailand-Myanmar border. Trans. R. Soc. Trop. Med. Hyg. 105(1), 32-37 (2011).
80. Compton J. Nucleic acid sequence-based amplification. Nature 350(6313), 91-92 (1991).
81. Wu SJ, Lee EM, Putvatana R et al. Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay. J. Clin. Microbiol. 39(8), 2794-2798 (2001).
82. Bhatnagar J, Blau DM, Shieh WJ et al. Molecular detection and typing of dengue viruses from archived tissues of fatal cases by rt-PCR and sequencing: diagnostic and epidemiologic implications. Am. J. Trop. Med. Hyg. 86(2), 335-340 (2012).
83. Peeling RW, Artsob H, Pelegrino JL et al. Evaluation of diagnostic tests: dengue. Nat. Rev. Microbiol. 8(12 Suppl.), S30-S38 (2010).
84. Winkler G, Maxwell SE, Ruemmler C, Stollar V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171(1), 302-305 (1989).
85. Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73(7), 6104-6110 (1999).
86. Libraty DH, Young PR, Pickering D et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186(8), 1165-1168 (2002).
87. Avirutnan P, Punyadee N, Noisakran S et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193(8), 1078-1088 (2006).
88. Hang VT, Nguyet NM, Trung DT et al. Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl. Trop. Dis. 3(1), e360 (2009).
89. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzymelinked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38(3), 1053-1057 (2000).
90. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40(2), 376-381 (2002).
91. Dussart P, Labeau B, Lagathu G et al. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin. Vaccine Immunol. 13(11), 1185-1189 (2006).
92. Xu H, Di B, Pan YX et al. Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: implications for early diagnosis and serotyping of dengue virus infections. J. Clin. Microbiol. 44(8), 2872-2878 (2006).
93. Kumarasamy V, Wahab AH, Chua SK et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J. Virol. Methods 140(1-2), 75-79 (2007).
94. Kumarasamy V, Chua SK, Hassan Z et al. Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med. J. 48(7), 669-673 (2007).
95. McBride WJ. Evaluation of dengue NS1 test kits for the diagnosis of dengue fever. Diagn. Microbiol. Infect. Dis. 64(1), 31-36 (2009).
96. Bessoff K, Delorey M, Sun W, Hunsperger E. Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection. Clin. Vaccine Immunol. 15(10), 1513-1518 (2008).
97. Blacksell SD, Mammen MP Jr, Thongpaseuth S et al. Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos. Diagn. Microbiol. Infect. Dis. 60(1), 43-49 (2008).
98. Bessoff K, Phoutrides E, Delorey M, Acosta LN, Hunsperger E. Utility of a commercial nonstructural protein 1 antigen capture kit as a dengue virus diagnostic tool. Clin. Vaccine Immunol. 17(6), 949-953 (2010).
99. Lima Mda R, Nogueira RM, Schatzmayr HG, dos Santos FB. Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl. Trop. Dis. 4(7), e738 (2010).
100. Wang SM, Sekaran SD. Evaluation of a commercial SD dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J. Clin. Microbiol. 48(8), 2793-2797 (2010).
101. Tricou V, Vu HT, Quynh NV et al. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect. Dis. 10, 142 (2010).
102. Blacksell SD, Jarman RG, Bailey MS et al. Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin. Vaccine Immunol. 18(12), 2095-2101 (2011).
103. Chaterji S, Allen JC Jr, Chow A, Leo YS, Ooi EE. Evaluation of the NS1 rapid test and the WHO dengue classification schemes for use as bedside diagnosis of acute dengue fever in adults. Am. J. Trop. Med. Hyg. 84(2), 224-228 (2011).
104. Lima MDA R, Noguieira RM, Schatzmayr HG, de Pilippis AM. A new approach to dengue fatal cases diagnosis: NS1 antigen capture in tissues. PLoS Negl. Trop. Dis. 5(5), e1147 (2011).
105. Ding X, Hu D, Chen Y et al. Full serotype-and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection. Clin. Vaccine Immunol. 18(3), 430-434 (2011).
106. Shu PY, Chen LK, Chang SF et al. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 62(2), 224-232 (2000).
107. Shu PY, Chen LK, Chang SF et al. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J. Clin. Microbiol. 40(5), 1840-1844 (2002).
108. Shu PY, Chen LK, Chang SF et al. Dengue virus serotyping based on envelope and membrane and nonstructural protein NS1 serotype-specific capture immunoglobulin M enzyme-linked immunosorbent assays. J. Clin. Microbiol. 42(6), 2489-2494 (2004).
109. Puttikhunt C, Prommool T, U-thainual N et al. The development of a novel serotyping-NS1-ELISA to identify serotypes of dengue virus. J. Clin. Virol. 50(4), 314-319 (2011).
110. Watanabe S, Tan KH, Rathore AP et al. The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model. J. Virol. 86(10), 5508-5514 (2012).
111. De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz. J. Infect. Dis. 8(6), 390-398 (2004).
112. Innis BL, Nisalak A, Nimmannitya S et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40(4), 418-427 (1989).
113. Kuno G, Gómez I, Gubler DJ. An ELISA procedure for the diagnosis of dengue infections. J. Virol. Methods 33(1-2), 101-113 (1991).
114. Lam SK, Fong MY, Chungue E et al. Multicentre evaluation of dengue IgM dot enzyme immunoassay. Clin. Diagn. Virol. 7(2), 93-98 (1996).
115. Hunsperger EA, Yoksan S, Buchy P et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerging Infect. Dis. 15(3), 436-440 (2009).
116. Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin. Diagn. Lab. Immunol. 7(6), 867-871 (2000).
117. Prince HE, Matud JL. Estimation of dengue virus IgM persistence using regression analysis. Clin. Vaccine Immunol. 18(12), 2183-2185 (2011).
118. Blacksell SD, Doust JA, Newton PN, Peacock SJ, Day NP, Dondorp AM. A systematic review and meta-analysis of the diagnostic accuracy of rapid immunochromatographic assays for the detection of dengue virus IgM antibodies during acute infection. Trans. R. Soc. Trop. Med. Hyg. 100(8), 775-784 (2006).
119. Tomashek KM. Dengue fever & dengue hemorrhagic fever. In: CDC Health Information for International Travel 2010, The Yellow Book, Centers for Disease Control and Prevention. Gw B (Ed.). Oxford University Press, NC, USA (2010).
120. Prince HE, Yeh C, Lapé-Nixon M. Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay. Clin. Vaccine Immunol. 15(8), 1304-1306 (2008).
121. Russell PK, Nisalak A. Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 99(2), 291-296 (1967).
122. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99(2), 285-290 (1967).
123. Dulbecco R, Vogt M, Strickland AG. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2(2), 162-205 (1956).
124. Putnak JR, de la Barrera R, Burgess T et al. Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies. Am. J. Trop. Med. Hyg. 79(1), 115-122 (2008).
125. Roehrig JT, Hombach J, Barrett AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol. 21(2), 123-132 (2008).
126. Vorndam V, Beltran M. Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses. Am. J. Trop. Med. Hyg. 66(2), 208-212 (2002).
127. Martin NC, Pardo J, Simmons M et al. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J. Virol. Methods 134(1-2), 74-85 (2006).
128. Rodrigo WW, Alcena DC, Rose RC, Jin X, Schlesinger JJ. An automated dengue virus microneutralization plaque assay performed in human Fc{?} receptor-expressing CV-1 cells. Am. J. Trop. Med. Hyg. 80(1), 61-65 (2009).
129. Thomas SJ, Nisalak A, Anderson KB et al. Dengue plaque reducti on neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am. J. Trop. Med. Hyg. 81(5), 825-833 (2009).
130. Liu L, Wen K, Li J et al. Comparison of plaque-and enzyme-linked immunospotbased assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein. Clin. Vaccine Immunol. 19(1), 73-78 (2012).
131. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fc? receptor (Fc?R)-negative and Fc?Rexpressing BHK-21 cells. Clin. Vaccine Immunol. 17(3), 402-407 (2010).
132. Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I. Dengue virus infectionenhancing activity in serum samples with neutralizing activity as determined by using Fc?R-expressing cells. PLoS Negl. Trop. Dis. 6(2), e1536 (2012).
133. Chan KR, Zhang SL, Tan HC et al. Ligation of Fc ? receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc. Natl Acad. Sci. USA 108(30), 12479-12484 (2011).
134. Ramos MM, Tomashek KM, Arguello DF et al. Early clinical features of dengue infection in Puerto Rico. Trans. R. Soc. Trop. Med. Hyg. 103(9), 878-884 (2009).
135. Aytur T, Foley J, Anwar M, Boser B, Harris E, Beatty PR. A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis. J. Immunol. Methods 314(1-2), 21-29 (2006).
136. Lee YF, Lien KY, Lei HY, Lee GB. An integrated microfluidic system for rapid diagnosis of dengue virus infection. Biosens. Bioelectron. 25(4), 745-752 (2009).
137. Duval D, González-Guerrero AB, Dante S et al. Nanophotonic lab-on-a-chip platforms including novel bimodal interferometers, microfluidics and grating couplers. Lab Chip 12(11), 1987-1994 (2012).
138. Fang X, Tan OK, Tse MS, Ooi EE. A label-free immunosensor for diagnosis of dengue infection with simple electrical measurements. Biosens. Bioelectron. 25(5), 1137-1142 (2010).
139. Lee VJ, Lye DC, Sun Y, Leo YS. Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore. Trop. Med. Int. Health 14(9), 1154-1159 (2009).
140. Thein TL, Leo YS, Lee VJ, Sun Y, Lye DC. Validation of probability equation and decision tree in predicting subsequent dengue hemorrhagic fever in adult dengue inpatients in Singapore. Am. J. Trop. Med. Hyg. 85(5), 942-945 (2011).
141. Peeling RW, Smith PG, Bossuyt PM. A guide for diagnostic evaluations. Nat. Rev. Microbiol. 8(12 Suppl.), S2-S6 (2010).
142. Shrestha B, Brien JD, Sukupolvi-Petty S et al. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 6(4), e1000823 (2010).
143. Gromowski GD, Roehrig JT, Diamond MS, Lee JC, Pitcher TJ, Barrett AD. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape. Virology 407(2), 237-246 (2010).
144. Ma Q, Wang Y. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J. Med. Virol. 84(2), 198-206 (2012).
145. Kalayanarooj S, Vaughn DW, Nimmannitya S et al. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 176(2), 313-321 (1997).
146. Kittigul L, Pitakarnjanakul P, Sujirarat D, Siripanichgon K. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J. Clin. Virol. 39(2), 76-81 (2007).
147. Phuong CX, Nhan NT, Kneen R et al.; Dong Nai Study Group. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful? Am. J. Trop. Med. Hyg. 70(2), 172-179 (2004).
148. Chau TN, Anders KL, Lien le B et al. Clinical and virological features of dengue in Vietnamese infants. PLoS Negl. Trop. Dis. 4(4), e657 (2010).
149. Nunes-Araújo FR, Ferreira MS, Nishioka SD. Dengue fever in Brazilian adults and children: assessment of clinical findings and their validity for diagnosis. Ann. Trop. Med. Parasitol. 97(4), 415-419 (2003).
150. Alexander N, Balmaseda A, Coelho IC et al.; on behalf of the European Union, World Health Organization (WHO-TDR) supported DENCO Study Group. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop. Med. Int. Health 16(8), 936-948 (2011).
151. Fry SR, Meyer M, Semple MG et al. The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Negl. Trop. Dis. 5(6), e1199 (2011).
152. Giraldo D, Sant'Anna C, Périssé AR et al. Characteristics of children hospitalized with dengue fever in an outbreak in Rio de Janeiro, Brazil. Trans. R. Soc. Trop. Med. Hyg. 105(10), 601-603 (2011).
153. Binh PT, Matheus S, Huong VT, Deparis X, Marechal V. Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults. J. Clin. Virol. 45(4), 276-280 (2009).
154. Leo YS, Thein TL, Fisher DA et al. Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study. BMC Infect. Dis. 11, 123 (2011).
155. Ong A, Sandar M, Chen MI, Sin LY. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int. J. Infect. Dis. 11(3), 263-267 (2007).